Kiyoshi Fujiwara
Overview
Explore the profile of Kiyoshi Fujiwara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsushita K, Miyazaki A, Miyake M, Izumi C, Matsutani H, Shimada M, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
7:100317.
PMID: 39712283
Background: There is a high prevalence of menstrual disturbance in women with congenital heart disease (CHD). The purpose of this study was to evaluate ovarian function in women with CHD...
2.
Kanayama S, Nakagawa E, Ueno S, Muraji M, Wakahashi S, Sudo T, et al.
World J Oncol
. 2017 Nov;
5(2):62-67.
PMID: 29147379
Background: Currently, there is no standardized follow-up protocol for patients who undergo laser conization. Therefore, we retrospectively investigated the clinical outcomes of laser conization in patients with high-grade cervical intraepithelial...
3.
Tanioka M, Yamaguchi S, Shimada M, Nagao S, Takehara K, Nishimura M, et al.
Med Oncol
. 2017 Jul;
34(8):134.
PMID: 28681218
The aim of this study is to evaluate the outcome and safety of the multidisciplinary strategy using cisplatin plus dose-dense paclitaxel (dose-dense TP) before and after radical hysterectomy (RH) for...
4.
Morimoto A, Nagao S, Kogiku A, Yamamoto K, Miwa M, Wakahashi S, et al.
Jpn J Clin Oncol
. 2016 Mar;
46(6):517-21.
PMID: 26977055
Objective: The purpose of this study is to investigate the clinical characteristics to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in patients with advanced epithelial ovarian...
5.
Kawakami F, Mikami Y, Sudo T, Fujiwara K, Hirose T, Itoh T
Diagn Cytopathol
. 2015 Jul;
43(10):791-6.
PMID: 26173165
Background: Gastric-type mucinous carcinoma (GAS) is a clinically aggressive variant of cervical adenocarcinoma. This study sought to describe the cytologic features of GAS. Methods: We reviewed the cervical and endometrial...
6.
Nagao S, Miwa M, Maeda N, Kogiku A, Yamamoto K, Morimoto A, et al.
Int J Gynecol Cancer
. 2015 Jul;
25(7):1300-5.
PMID: 26166556
Objective: Neuroendocrine carcinoma of the cervix is a rare and aggressive subtype of cervical cancer and includes small cell neuroendocrine carcinoma (SCNEC) and large cell neuroendocrine carcinoma (LCNEC). We conducted...
7.
Nagao S, Nishio S, Okada S, Otsuki T, Fujiwara K, Tanabe H, et al.
Cancer Chemother Pharmacol
. 2015 Jun;
76(2):335-42.
PMID: 26092322
Purpose: We previously reported that the concept of "platinum sensitivity" could be applied to recurrent endometrial cancer. We conducted an ancillary analysis to determine an appropriate second-line regimen for patients...
8.
Kato T, Takashima A, Kasamatsu T, Nakamura K, Mizusawa J, Nakanishi T, et al.
Gynecol Oncol
. 2015 Feb;
137(1):34-9.
PMID: 25662625
Objective: In order to determine indications for less radical surgery such as modified radical hysterectomy, the risk of pathological parametrial involvement and prognosis of FIGO stage IB1 cervical cancer patients...
9.
Matsumoto K, Yaegashi N, Iwata T, Ariyoshi K, Fujiwara K, Shiroyama Y, et al.
Jpn J Clin Oncol
. 2014 Aug;
44(10):1000-3.
PMID: 25098705
We have developed a collaborative hospital-based approach to monitoring the impact of a human papillomavirus vaccine on cervical cancer, its precursor lesions and human papillomavirus type-specific prevalence in Japan. The...
10.
Takase N, Matsumoto K, Onoe T, Kitao A, Tanioka M, Kikukawa Y, et al.
Int J Clin Oncol
. 2014 Jul;
20(3):566-73.
PMID: 25030546
Background: Platinum agents are essential for treating gynecological malignancies, particularly ovarian cancer. However, multiple carboplatin doses may cause hypersensitivity reactions (HSRs). Carboplatin desensitization prevents life-threatening HSRs and promotes the successful...